The validity period of NMPA registration for invasive blood pressure monitoring devices in China is typically 5 years. This registration period aligns with the regulatory requirement for most medical devices under the NMPA's oversight.

After obtaining NMPA registration, manufacturers must ensure ongoing compliance with regulatory requirements, including maintaining the quality management system, monitoring post-market surveillance, and reporting any adverse events or changes that may affect the device's safety or performance.

Prior to the expiration of the registration certificate, manufacturers are responsible for submitting a renewal application to the NMPA to continue marketing their invasive blood pressure monitoring devices in China. This renewal process involves demonstrating continued compliance with regulatory standards and providing updated documentation as required by the NMPA.

Contact Us：

Whatsapp or Wechat：+86 15816864648；email address：hito.lin@grzan.cn